221 related articles for article (PubMed ID: 17312680)
1. Clinical features and specific immunological response to Borrelia afzelii in patients with acrodermatitis chronica atrophicans.
Flisiak I; Schwartz RA; Chodynicka B
J Med; 1999; 30(3-4):267-78. PubMed ID: 17312680
[TBL] [Abstract][Full Text] [Related]
2. Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrophicans lesions.
Picken RN; Strle F; Picken MM; Ruzic-Sabljic E; Maraspin V; Lotric-Furlan S; Cimperman J
J Invest Dermatol; 1998 Mar; 110(3):211-4. PubMed ID: 9506437
[TBL] [Abstract][Full Text] [Related]
3. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
4. Histopathology and immunophenotype of acrodermatitis chronica atrophicans correlated with ospA and ospC genotypes of Borrelia species.
Brandt FC; Ertas B; Falk TM; Metze D; Böer-Auer A
J Cutan Pathol; 2015 Oct; 42(10):674-92. PubMed ID: 26156537
[TBL] [Abstract][Full Text] [Related]
5. Acrodermatitis chronica atrophicans in an 11-year-old girl.
Muellegger RR; Schluepen EM; Millner MM; Soyer HP; Volkenandt M; Kerl H
Br J Dermatol; 1996 Oct; 135(4):609-12. PubMed ID: 8915157
[TBL] [Abstract][Full Text] [Related]
6. Isolation of Borrelia burgdorferi sensu lato from a fibrous nodule in a patient with acrodermatitis chronica atrophicans.
Maraspin V; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):533-4. PubMed ID: 12422596
[TBL] [Abstract][Full Text] [Related]
7. Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients.
Ogrinc K; Maraspin V; Lusa L; Cerar Kišek T; Ružić-Sabljić E; Strle F
J Intern Med; 2021 Aug; 290(2):335-348. PubMed ID: 33550695
[TBL] [Abstract][Full Text] [Related]
8. [Chronic atrophic acrodermatitis; a deceptive form of Lyme borreliosis].
Tazelaar DJ; Velders AJ; de Koning J; Hoogkamp-Korstanje JA
Ned Tijdschr Geneeskd; 1991 Jul; 135(30):1358-63. PubMed ID: 1865945
[TBL] [Abstract][Full Text] [Related]
9. Rheumatic manifestations related to acrodermatitis chronica atrophicans. A review of four cases.
Gerster JC; Peter O
Rev Rhum Engl Ed; 1998 Oct; 65(10):567-70. PubMed ID: 9809360
[TBL] [Abstract][Full Text] [Related]
10. Western blot banding pattern in early Lyme borreliosis among patients from an endemic region of north-eastern Poland.
Flisiak R; Wierzbicka I; Prokopowicz D
Rocz Akad Med Bialymst; 1998; 43():210-20. PubMed ID: 9972057
[TBL] [Abstract][Full Text] [Related]
11. [Skin manifestations of Lyme borreliosis in patients at the 1st Dermato-venereologic Clinic of Comenius University Medical School in Bratislava 1996-1998].
Svecová D; Buchvald J; Oprsalová K; Dolezalová A
Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):115-22. PubMed ID: 11040493
[TBL] [Abstract][Full Text] [Related]
12. [Chronic atrophic acrodermatitis].
Kosbab R; Thess G; Köstler E
Dermatol Monatsschr; 1989; 175(11):685-90. PubMed ID: 2612709
[TBL] [Abstract][Full Text] [Related]
13. [Antibodies against Borrelia afzelli in patients with an early stage of Lyme disease].
Flisiak I; Chodynicka B
Wiad Lek; 2001; 54(1-2):19-25. PubMed ID: 11344697
[TBL] [Abstract][Full Text] [Related]
14. Expanding the clinicopathological spectrum of late cutaneous Lyme borreliosis (acrodermatitis chronica atrophicans [ACA]): A prospective study of 20 culture- and/or polymerase chain reaction (PCR)-documented cases.
Lenormand C; Jaulhac B; Debarbieux S; Dupin N; Granel-Brocard F; Adamski H; Barthel C; Cribier B; Lipsker D
J Am Acad Dermatol; 2016 Apr; 74(4):685-92. PubMed ID: 26781226
[TBL] [Abstract][Full Text] [Related]
15. Serological follow-up after treatment of Borrelia arthritis and acrodermatitis chronica atrophicans.
Hammers-Berggren S; Lebech AM; Karlsson M; Andersson U; Hansen K; Stiernstedt G
Scand J Infect Dis; 1994; 26(3):339-47. PubMed ID: 7939435
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans.
Hulshof MM; Vandenbroucke JP; Nohlmans LM; Spanjaard L; Bavinck JN; Dijkmans BA
Arch Dermatol; 1997 Jan; 133(1):33-7. PubMed ID: 9006370
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies against Borrelia afzelii, Borrelia burgdorferi sensu stricto and the 41-kiloDalton flagellin in patients from a Lyme borreliosis endemic area: analysis by EIA and immunoblot.
Nilsson I; von Rosen IA
APMIS; 1996 Dec; 104(12):907-14. PubMed ID: 9048870
[TBL] [Abstract][Full Text] [Related]
18. [Skin manifestations of Lyme borreliosis].
Nammous AH; Zubacki D; Dobrzycki I
Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
[TBL] [Abstract][Full Text] [Related]
19. Acrodermatitis chronica atrophicans in children: Report on two cases and review of the literature.
Maraspin V; Mrvič T; Ružić-Sabljić E; Jurčić V; Strle F
Ticks Tick Borne Dis; 2019 Jan; 10(1):180-185. PubMed ID: 30389325
[TBL] [Abstract][Full Text] [Related]
20. Anetoderma and borreliosis: is there a pathogenetic relationship?
Hofer T; Goldenberger D; Itin PH
Eur J Dermatol; 2003; 13(4):399-401. PubMed ID: 12948924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
